What are you looking for?
Need help finding what you are looking for? Contact Us

PUBLISHER: Nicholas Hall & Company | PRODUCT CODE: 1029516

Cover Image

PUBLISHER: Nicholas Hall & Company | PRODUCT CODE: 1029516

Sexual Health & Fertility

PAGES: 258 Pages
DELIVERY TIME: 1-2 business days
PDF (Site License)
USD 10455
PDF (Global License)
USD 12300

Add to Cart

"Sexual health is one of the biggest growth prospects in our industry. Whether we are talking about conception products, contraceptives or ED remedies, there is a strong public health case for more favourable regulations, right across the spectrum from helping to prevent unwanted teenage pregnancies to ensuring that fake Viagra is stamped out on the internet." - Nicholas Hall.

Sexual Health & Fertility is a vibrant area of the consumer healthcare field, encompassing a broad assortment of products, from VMS to home diagnostics, and awash with possibilities for expansion.

Tracking activity across Contraception, Fertility & Pregnancy, Sexual Health Problems, Intimate Care & more , this report aims to:

  • Investigate the current landscape across different markets
  • Profile key brands, including success factors
  • Highlight ongoing trends & new developments
  • Track NPD and Rx-to-OTC switch activity
  • Showcase examples of promotional activity
  • Utilise sales data (from our dedicated DB6 database) for selected categories
  • Examine what the future holds and forecast most likely future scenarios

Coverage includes recent developments such as Europe's centralised Rx-to-OTC switch and rollout of a topical spray for premature ejaculation , the UK's approval of daily oral contraceptive pills without prescription, and the push to make them OTC in USA. The nascent market for erectile dysfunction treatments is fully explored, including future prospects and potential size of the market. The report dives into the booming FemTech (female health technology) sector, encompassing a host of technologies focused on period care, fertility, pregnancy, menopause and sexual health.

TOPICS covered in this report:


  • Daily OCs
  • EHC
  • Condoms
  • Alternative methods

Fertility & Pregnancy

  • Pregnancy tests
  • Ovulation tests
  • Other home diagnostics
  • Pregnancy & pre-pregnancy vitamins
  • Other fertility & pregnancy CHC


  • Female health technology
  • Fertility & birth control apps

Sexual Health Problems

  • Erectile dysfunction
  • Premature ejaculation
  • Female sexual dysfunction
  • Sexually Transmitted Diseases

Intimate Care

  • Feminine intimate care
  • Male intimate care


  • Period pain
  • Premenstrual syndrome
  • Menopause

Table of Contents


  • Sexual Health & Fertility intro
  • Sexual Health & Fertility in the news
  • Birth and fertility rates declining, particularly in developed markets
  • Pandemic's effects on sexual activity mixed
  • Female empowerment a significant growth driver


  • 2019 UN study provides insight into birth control use worldwide

Daily OC

  • UN reports significant increase in daily OC use 1994-2019
  • Overview of key ingredients
  • Potential for category to expand outside Asia
  • China's dominant brand Yasmin benefits from challenging A+P
  • South Korea's market opening up via NPD
  • India sees daily OC reform
  • Round-up of other markets
  • Switches in UK may open up European market
  • Category has potential for expansion in the long term

Emergency Hormonal Contraception

  • Broad geographic availability, but challenges remain
  • USA dominated by single marketer
  • Plan B One-Step a key player in the US market
  • China's No.1 brand supported by extensive health education
  • India faces challenge from widened availability of daily OC
  • Italy slow to liberalise EHC market, but saw sales surge in 2021
  • Germany faces growing generic competition for brands
  • Plan B and ellaOne key players in other top markets
  • Steady growth, with some potential for switches


  • Popular form of contraception seeing diversification of key brands
  • In USA lower-tier options outperformed established leading brands
  • Marketing in Brazil promotes safe and enjoyable sex
  • Trojan retains commanding lead in USA thanks to focus on pleasure
  • Durex has built a foundation of socially-conscious marketing
  • Female condoms a growing segment

Other Contraceptives

  • Spermicides available in pharmacies in certain markets
  • Alternative methods generally HCP-focused

Fertility & Pregnancy

Pregnancy & Ovulation Tests

  • Established category with generally high demand
  • Consumerised US market maintained growth
  • Clearblue an international success via many firsts
  • First Response focuses on speed of results
  • US innovations driven by female-led companies
  • Modern Fertility focuses on building a community
  • Clearblue an innovative presence in UK
  • Generic competition significant in Germany
  • First Response a bright spot in Australian market
  • Sales in Brazil dynamic despite lack of A+P
  • Generics a significant presence in France

Pregnancy & Pre-pregnancy Vitamins

  • Conception through to pregnancy
  • Key vitamins & their benefits
  • Importance of HCPs / NPD focus
  • Global trends
  • USA bolstered by NPD and premium-price launches
  • China finds growth despite falling birth rates
  • Italy sees top tier perform well
  • Germany dynamic thanks to increasing birth rate
  • Mexico sees strong showing from leading brands
  • Brazil's strong growth driven by two dominant brands
  • Global leading brands
  • Elevit global leading pregnancy vitamin range
  • Femibion a key brand in Europe
  • Outlook
  • Male fertility VMS offers burgeoning niche

Other Fertility CHC

  • Fertility lubricants: Small segment sees growing interest


  • One size does not fit all in women's health
  • Clue an early entrant in FemTech segment
  • Natural Cycles offers a first-in-class birth control app
  • Elvie addresses breastfeeding and pelvic floor exercise
  • Peptonic Medical building portfolio of FemTech brands
  • Vira Health developing innovative menopause app
  • Prima-Temp partners with CHC brand Enfamil
  • Vivant extends FemTech apps into India and other Asian markets
  • Conclusions

Sexual Health Problems

  • Broad range of issues partially addressed by OTC

Erectile Dysfunction

  • Most common sexual dysfunction in men
  • Sildenafil-based treatments OTC in a handful of markets
  • Poland boasts largest OTC market for ED treatments in 2021
  • UK market created by switch of Viagra
  • Viagra Connect makes OTC debut in UK
  • New Zealand sees "first in world" OTC reclassification for ED
  • Topical options include Futura's MED3000 ED gel
  • Switch prospects
  • Forecasts predict a category that could skyrocket with switches
  • "Male vitality" supplements offer VMS alternative
  • USA offers array of supplements for sexual performance
  • Russia's sexual health supplements continue to decline
  • Limited selection in other markets
  • Latest launch activity offers little innovation

Premature Ejaculation

  • Prevalence and treatment options
  • Fortacin's EU-wide switch brings new OTC treatment

Female Sexual Dysfunction

  • Complex condition slowly gaining acceptance
  • Available treatment options for FSD

Sexually Transmitted Diseases

  • Access to STD testing via health services commonplace
  • Treatment likely to remain Rx but self testing a growing segment
  • Growing number of home HIV tests in Europe
  • Growing number of markets liberalising access to HIV tests myLAB BOX a key player in US STD testing
  • OraQuick groundbreaking oral HIV test / Better2Know premium test kits
  • SH:24 in UK bridges gap between HCPs and self-testing
  • FemiClear offers relief of genital herpes symptoms
  • Self-tests for chlamydia a small segment in German pharmacy market

Intimate Care

  • Feminine intimate care has good global spread
  • China's FIC market dominated by domestic brands
  • USA's FIC growth boosted by NPD and high levels of A+P
  • Honey Pot premium FIC range causing a buzz
  • Large French FIC market struggled in recent years
  • Italy's FIC market experiencing ups and downs
  • Vagisan holds lead of German FIC despite increasing competition
  • Russian FIC market expanded by NPD
  • Brazil sees high levels of NPD boost FIC growth
  • Poland FIC market seeing increasing crossover with sexual health
  • Global FIC growth expected to accelerate as taboos break down
  • VYI brands increasingly branching into FIC
  • Growing trend for male intimate care


Period Pain

  • Niche for menstrual pain growing worldwide
  • In USA Midol faces growing competition from big pain relief brands
  • In China MNCs fight for share with domestic TCM brands
  • Japan has well-developed niche for menstrual pain
  • Brazil menstrual pain segment developing rapidly
  • Room for development in many key European markets
  • Breaking stigma key to building the market in India


  • Premenstrual syndrome and premenstrual dysphoric disorder
  • Causes & symptoms of PMS
  • Common ingredients to alleviate PMS
  • Launch activity among branded PMS remedies
  • Flo claims to be first PMS remedy in gummy format
  • Consumer preference for drug-free remedies boosts sales of AZO Hormonal
  • Oxaloacetate, ingredient approved for PMS symptoms


  • Herbal menopause supplements sales static globally
  • China's herbal menopause supplements growing well
  • New launches could expand struggling US market
  • Japan's sales hit hard by Covid-19 pandemic
  • European markets in need of a boost
  • Mexico sees category slowly becoming more consumer-oriented
  • Herbal menopause supplements in need of innovation
Have a question?

Jeroen Van Heghe

Manager - EMEA



Christine Sirois

Manager - Americas


Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!